Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
Friend
P J
PJ
Department of Surgery, University of Cambridge, Addenbrooke's Hospital, England.
Waldmann
H
H
Hale
G
G
Cobbold
S
S
Rebello
P
P
Thiru
S
S
Jamieson
N V
NV
Johnston
P S
PS
Calne
R Y
RY
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015703:Antigens, CD / Q000627:therapeutic use*; D000951:Antigens, Neoplasm; D000074301:CD52 Antigen; D006023:Glycoproteins; D006084:Graft Rejection; D007165:Immunosuppression Therapy; D007262:Infusions, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D016853:Muromonab-CD3; D010865:Pilot Projects; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D000074301:CD52 Antigen; D006023:Glycoproteins; D016853:Muromonab-CD3